Publication:
CPAP therapy may improve HFpEF-like features in coronary artery disease with obstructive sleep apnea: a randomized controlled trial

Simple item page
dc.contributor.coauthorPihtili, A.
dc.contributor.coauthorGlantz, H.
dc.contributor.coauthorThunström, E.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorPeker, Yüksel
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-07-19T19:48:39Z
dc.date.issued2026
dc.description.abstractObstructive sleep apnea (OSA) frequently coexists with coronary artery disease (CAD) and may contribute to heart failure with preserved ejection fraction (HFpEF). Whether HFpEF-like features are reversible with continuous positive airway pressure (CPAP) therapy remains uncertain. Methods A total of 177 revascularized CAD patients with nonsleepy OSA (Epworth Sleepiness Scale score
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThe RICCADSA trial was supported by grants from the Swedish Research Council (521-2011-537 and 521-2013-3439) ; the Swedish Heart-Lung Foundation (20080592, 20090708 and 20100664) ; the "Agreement concerning research and education of doctors" of Vastra Gotalandsregionen (ALFGBG-11538 and ALFGBG-150801) , Research fund at Skaraborg Hospital (VGSKAS-4731, VGSKAS-5908, VGSKAS-9134, VGSKAS-14781, VGSKAS-40271 and VGSKAS-116431) ; Skaraborg Research and Development Council (VGFOUSKB-46371) ; the Heart Foundation of Karnsjukhuset; ResMed Foundation; and ResMed Ltd.
dc.description.versionPublished Version
dc.identifier.ScopusPercentile89
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile78.2
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.sleep.2026.109069
dc.identifier.eissn1878-5506
dc.identifier.embargoN/A
dc.identifier.grantno20080592
dc.identifier.grantno521-2011-537
dc.identifier.grantno521-2013-3439
dc.identifier.grantnoVGSKAS-4731
dc.identifier.grantnoALFGBG-11538
dc.identifier.issn1389-9457
dc.identifier.pubmed42250441
dc.identifier.scopus2-s2.0-105041070703
dc.identifier.urihttp://doi.org/10.1016/j.sleep.2026.109069
dc.identifier.urihttps://hdl.handle.net/20.500.14288/33563
dc.identifier.volume146
dc.identifier.wos001794485100001
dc.keywordsCoronary artery disease
dc.keywordsContinuous positive airway pressure
dc.keywordsHeart failure with preserved ejection fraction like phenotype
dc.keywordsObstructive sleep apnea
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofSleep Medicine
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectCoronary artery disease
dc.subjectContinuous positive airway pressure
dc.subjectHeart failure with preserved ejection fraction like phenotype
dc.subjectObstructive sleep apnea
dc.titleCPAP therapy may improve HFpEF-like features in coronary artery disease with obstructive sleep apnea: a randomized controlled trial
dc.typeJournal Article
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext